Funds and ETFs Iqvia Holdings Inc.

Equities

IQV

US46266C1053

Biotechnology & Medical Research

Market Closed - Nyse 04:00:02 2024-05-10 pm EDT 5-day change 1st Jan Change
234.1 USD +2.13% Intraday chart for Iqvia Holdings Inc. +4.79% +1.17%

ETFs positioned on Iqvia Holdings Inc.

Name Weight AuM 1st Jan change Investor Rating
0.11% 0 M€ +5.63% -
0.11% 0 M€ +1.41% -
0.11% 0 M€ +5.63% -
0.11% 0 M€ +11.62% -
0.11% 0 M€ +12.13% -
0.10% 1 M€ -.--%
0.10% 786 M€ -.--%
0.10% 23 M€ -.--% -
0.10% 0 M€ +19.88% -
0.10% 206 M€ -.--%
0.10% 284 M€ -.--%
0.09% 1,006 M€ -.--%
0.09% 414 M€ +11.90% -
0.09% 322 M€ +13.88%
0.09% 29 M€ -.--% -
0.09% 1,174 M€ +23.54%
0.09% 655 M€ -.--% -
0.09% 273 M€ -.--%
0.09% 0 M€ +18.92%
0.08% 14 M€ +16.19% -
0.07% 1,166 M€ +0.26%
0.07% 607 M€ +0.05%
0.06% 205 M€ -.--%
0.06% 0 M€ 0.00% -
0.06% 0 M€ +6.85% -
0.05% 0 M€ +8.70% -
0.05% 0 M€ +7.95% -
0.04% 0 M€ +5.79% -
0.04% 0 M€ +5.63% -
Iqvia Holdings Inc. is one of the world's leading companies specializing in information, analytics, research and healthcare services based on technology solutions. Net sales break down by activity as follows: - development of contract research and clinical development solutions and services (54.5%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical studies, develop new therapeutic classes, identify treatment needs and assess the efficacy of pharmaceuticals with a view to improving clinical and scientific outcomes; - development of technology and analytics solutions (39.9%): services related to information, analysis, strategic consulting, marketing studies and short-term healthcare-market studies, business processes outsourcing, and management of medical-administrative databases, all aimed at optimizing the performance and commercial strategies of pharmaceutical companies and health workers; - integrated services (5.6%): development and implementation of customized solutions and customer engagement programs, healthcare services, scientific and medical services, etc. Net sales are distributed geographically as follows: Americas (49.4%), Europe and Africa (31.4%) and Asia/Pacific (19.2%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
234.1 USD
Average target price
271.4 USD
Spread / Average Target
+15.96%
Consensus
  1. Stock Market
  2. Equities
  3. IQV Stock
  4. Funds and ETFs Iqvia Holdings Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW